|
MGC57346 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.206400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.236370E-01 |
| Normal-vs-Stage2 |
7.225000E-01 |
| Normal-vs-Stage3 |
1.053810E-01 |
| Normal-vs-Stage4 |
7.772500E-02 |
| Stage1-vs-Stage2 |
3.318800E-01 |
| Stage1-vs-Stage3 |
9.94029999999979E-05 |
| Stage1-vs-Stage4 |
2.032600E-04 |
| Stage2-vs-Stage3 |
6.793900E-02 |
| Stage2-vs-Stage4 |
5.744500E-02 |
| Stage3-vs-Stage4 |
6.885200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.548600E-01 |
| Normal-vs-AfricanAmerican |
8.140000E-01 |
| Normal-vs-Asian |
2.949600E-01 |
| Caucasian-vs-AfricanAmerican |
7.220800E-01 |
| Caucasian-vs-Asian |
9.382000E-02 |
| AfricanAmerican-vs-Asian |
1.520210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.873800E-01 |
| Normal-vs-Female |
4.770800E-01 |
| Male-vs-Female |
1.463570E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.338400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.777400E-01 |
| Normal-vs-Age(61-80Yrs) |
6.090800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.631800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.989600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.755800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.885000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.396200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.358000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.973000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.817700E-02 |
| Normal-vs-Grade 2 |
1.212360E-01 |
| Normal-vs-Grade 3 |
7.048000E-01 |
| Normal-vs-Grade 4 |
7.606100E-04 |
| Grade 1-vs-Grade 2 |
1.432370E-01 |
| Grade 1-vs-Grade 3 |
2.100500E-02 |
| Grade 1-vs-Grade 4 |
5.81760000000209E-05 |
| Grade 2-vs-Grade 3 |
8.279000E-03 |
| Grade 2-vs-Grade 4 |
3.82039999635708E-08 |
| Grade 3-vs-Grade 4 |
8.562900E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.873800E-02 |
| Normal-vs-ccB subtype |
5.071800E-01 |
| ccA subtype-vs-ccB subtype |
1.615640E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.440600E-01 |
| Normal-vs-N1 |
6.850600E-01 |
| N0-vs-N1 |
5.303000E-01 |
|
|
